Literature DB >> 24238726

[Intra-abdominal hypertension: effects on the splanchnic circulation. Preliminary study in a model of ascites].

Laura Correa-Martín1, Gregorio Castellanos2, Mónica García-Lindo3, Idoia Díaz-Güemes4, Antonio Piñero2, Francisco Miguel Sánchez-Margallo4.   

Abstract

INTRODUCTION: Intra-abdominal hypertension is defined as a rise in intra-abdominal pressure leading to progressive dysfunction of the abdominal organs.
OBJECTIVE: To evaluate the effects of intra-abdominal hypertension on the splanchnic circulation in a porcine animal model with a view to determining the diagnostic method of choice.
MATERIAL AND METHODS: A total of 10 swine were divided into 2 groups: a control group and a group with an ascites pressure of 20mmHg. Transvesical and transperitoneal intra-abdominal pressures were registered, and the correlation between the measurements obtained was determined. Concentrations of lactic acid, alanine aminotransferase, glucose and gastric mucosal pH were also obtained. We registered the mean arterial and abdominal perfusion pressures, and the correlation of the latter with gastric mucosal pH and lactic acid concentrations. The parameters were registered for a total of 3hours.
RESULTS: We observed a high correlation between transvesical and transperitoneal measurements of intra-abdominal pressure (R(2)=0.98). In the 20mmHg pressure group, lactic acid concentrations increased significantly at 180min (p<0.011). Gastric mucosal pH differed significantly between the 2 groups from the beginning of the study (p=0.004) and significantly decreased from 120min onward. Mean arterial and abdominal perfusion pressures gradually decreased during the trial, with early significant changes in the abdominal perfusion pressure (p=0.001), and a good correlation with the remaining study parameters. There were no significant changes in hepatic indicators.
CONCLUSIONS: We believe the transvesical approach to be the technique of choice to determine intra-abdominal pressure. Abdominal perfusion pressure is a sensitive marker of intra-abdominal hypertension, and gastric mucosal pH is the first parameter to be affected.
Copyright © 2013 Elsevier España, S.L. and AEEH y AEG. All rights reserved.

Entities:  

Keywords:  Ascites; Ascitis; Experimental; Hipertensión intraabdominal; Intra-abdominal hypertension; Intra-abdominal pressure; Perfusion; Perfusión; Presión intraabdominal; Tonometry; Tonometría

Mesh:

Substances:

Year:  2013        PMID: 24238726     DOI: 10.1016/j.gastrohep.2013.08.002

Source DB:  PubMed          Journal:  Gastroenterol Hepatol        ISSN: 0210-5705            Impact factor:   2.102


  4 in total

1.  Intestinal histopathological changes in a porcine model of pneumoperitoneum-induced intra-abdominal hypertension.

Authors:  Ester Párraga Ros; Laura Correa-Martín; Francisco M Sánchez-Margallo; Irma Eugenia Candanosa-Aranda; Manu L N G Malbrain; Robert Wise; Rafael Latorre; Octavio López Albors; Gregorio Castellanos
Journal:  Surg Endosc       Date:  2018-05-17       Impact factor: 4.584

Review 2.  Gastric tonometry guided therapy in critical care patients: a systematic review and meta-analysis.

Authors:  Xin Zhang; Wei Xuan; Ping Yin; Linlin Wang; Xiaodan Wu; Qingping Wu
Journal:  Crit Care       Date:  2015-01-27       Impact factor: 9.097

3.  Time-course evaluation of intestinal structural disorders in a porcine model of intra-abdominal hypertension by mechanical intestinal obstruction.

Authors:  Ester Párraga Ros; Laura Correa-Martín; Francisco M Sánchez-Margallo; Irma Eugenia Candanosa-Aranda; Manu L N G Malbrain; Robert Wise; Rafael Latorre; Octavio López Albors; Gregorio Castellanos
Journal:  PLoS One       Date:  2018-01-22       Impact factor: 3.240

4.  Mechanical Intestinal Obstruction in a Porcine Model: Effects of Intra-Abdominal Hypertension. A Preliminary Study.

Authors:  L Correa-Martín; E Párraga; F M Sánchez-Margallo; R Latorre; O López-Albors; R Wise; M L N G Malbrain; G Castellanos
Journal:  PLoS One       Date:  2016-02-05       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.